{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:59:46Z","timestamp":1793149186998,"version":"4.5.0"},"reference-count":48,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.3201\/eid2411.180326","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T10:23:11Z","timestamp":1537870991000},"page":"2010-2020","source":"Crossref","is-referenced-by-count":123,"title":["Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010\u20132017"],"prefix":"10.3201","volume":"24","author":[{"given":"Kimiko","family":"Ubukata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Morozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Wajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michi","family":"Shouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Invasive Pneumococcal Diseases Surveillance Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2411.180326-201810110919-R1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"key-10.3201\/eid2411.180326-201810110919-R2","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2411.180326-201810110919-R3","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998-2003.","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2411.180326-201810110919-R4","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"key-10.3201\/eid2411.180326-201810110919-R5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2411.180326-201810110919-R6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R9","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2411.180326-201810110919-R10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2411.180326-201810110919-R11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2411.180326-201810110919-R13","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/cid\/ciu006","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.","volume":"58","author":"Angoulvant","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R14","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/cid\/ciu683","article-title":"Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent\/13-valent PCV.","volume":"59","author":"Ben-Shimol","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/civ067","article-title":"Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era.","volume":"60","author":"Kaplan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmi.2014.08.009","article-title":"Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network.","volume":"21","author":"Kempf","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2411.180326-201810110919-R17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2015.","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"key-10.3201\/eid2411.180326-201810110919-R18","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","article-title":"Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.","volume":"31","author":"Steens","year":"2013","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2411.180326-201810110919-R19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/infdis\/jiu213","article-title":"Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.","volume":"210","author":"Moore","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R20","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12916-016-0755-7","article-title":"Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.","volume":"14","author":"Alari","year":"2016","journal-title":"BMC Med"},{"key":"key-10.3201\/eid2411.180326-201810110919-R23","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10096-016-2868-5","article-title":"Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children.","volume":"36","author":"Hays","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/650496","article-title":"Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era.","volume":"201","author":"Gertz","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R25","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.diagmicrobio.2014.05.020","article-title":"Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine.","volume":"80","author":"Mendes","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1128\/JCM.02283-16","article-title":"The ongoing genetic adaptation of Streptococcus pneumoniae.","volume":"55","author":"Richter","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2411.180326-201810110919-R28","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1128\/JCM.01778-16","article-title":"Emergence of multidrug-resistant pneumococcal serotype 35B among children in the United States.","volume":"55","author":"Olarte","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2411.180326-201810110919-R29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12879-015-0941-9","article-title":"Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.","volume":"15","author":"van der Linden","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R30","doi-asserted-by":"publisher","first-page":"ofw020","DOI":"10.1093\/ofid\/ofw020","article-title":"Insight into resistance phenotypes of emergent non 13-valent pneumococcal conjugate vaccine type pneumococci isolated from invasive disease after 13-valent pneumococcal conjugate vaccine implementation in France.","volume":"3","author":"Janoir","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R31","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3201\/eid2007.131485","article-title":"Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan, 2010-2013.","volume":"20","author":"Chiba","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R32","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3201\/eid2111.142029","article-title":"Serotype changes and drug resistance in invasive pneumococcal diseases in adults after vaccinations in children, Japan, 2010\u20132013.","volume":"21","author":"Ubukata","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/mdr.2011.0102","article-title":"Application of the real-time PCR method for genotypic identification of \u03b2-lactam resistance in isolates from invasive pneumococcal diseases.","volume":"18","author":"Chiba","year":"2012","journal-title":"Microb Drug Resist"},{"key":"key-10.3201\/eid2411.180326-201810110919-R34","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 25th informational supplement (M100\u2013S25). Wayne (PA): The Institute; 2015."},{"key":"key-10.3201\/eid2411.180326-201810110919-R35","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R36","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination.","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"key-10.3201\/eid2411.180326-201810110919-R37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","article-title":"Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.","volume":"33","author":"Lepoutre","year":"2015","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2411.180326-201810110919-R38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/jpids\/piw005","article-title":"The effect of 13-valent pneumococcal conjugate vaccine on the serotype distribution and antibiotic resistance profiles in children with invasive pneumococcal disease.","volume":"6","author":"Gaviria-Agudelo","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.3201\/eid2411.180326-201810110919-R39","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/cid\/cix115","article-title":"Pneumococcal pneumonia requiring hospitalization in US children in the 13-valent pneumococcal conjugate vaccine era.","volume":"64","author":"Olarte","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R40","doi-asserted-by":"publisher","first-page":"D60","DOI":"10.1016\/j.vaccine.2015.05.102","article-title":"Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines.","volume":"33","author":"Pilishvili","year":"2015","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2411.180326-201810110919-R41","doi-asserted-by":"publisher","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany.","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2411.180326-201810110919-R42","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.vaccine.2017.11.085","article-title":"Invasive pneumococcal disease in children under 16\u202fyears of age: Incomplete rebound in incidence after the maximum effect of PCV13 in 2012\/13 in Germany.","volume":"36","author":"Weinberger","year":"2018","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2411.180326-201810110919-R43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","article-title":"Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study.","volume":"17","author":"Suzuki","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1086\/341072","article-title":"Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.","volume":"186","author":"Beall","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1128\/JCM.05895-11","article-title":"Multidrug-resistant Streptococcus pneumoniae serotype 6D clones in South Korea.","volume":"50","author":"Ko","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2411.180326-201810110919-R46","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1371\/journal.ppat.0030168","article-title":"Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.","volume":"3","author":"Brueggemann","year":"2007","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid2411.180326-201810110919-R47","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/infdis\/jis703","article-title":"Pneumococcal capsular switching: a historical perspective.","volume":"207","author":"Wyres","year":"2013","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2411.180326-201810110919-R48","doi-asserted-by":"publisher","first-page":"e00478","DOI":"10.1128\/AAC.00478-17","article-title":"Genome evolution to penicillin resistance in serotype 3 Streptococcus pneumoniae by capsular switching.","volume":"61","author":"Chiba","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/24\/11\/18-0326_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T22:27:51Z","timestamp":1755642471000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/24\/11\/18-0326_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2411.180326","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}